Article
Outcome in partial early virologic responders to combination therapy with peginterferon and ribavirin in patients infected with hepatitis C virus genotype 1b.
Journal of medical virology - 1 Jan 2011
Toyoda Hidenori, Kumada Takashi, Kiriyama Seiki, Tanikawa Makoto, Hisanaga Yasuhiro, Kanamori Akira, Tada Toshifumi, Hosokawa Takanori, Arakawa Takahiro, Fujimori Masashi
Abstract excerpt
The course and outcome in patients infected with hepatitis C virus (HCV) genotype 1b with partial early virologic response during combination therapy with peginterferon and ribavirin, in whom serum HCV RNA is detectable but has decreased by more than 2 log(10) 12 weeks after the start of the therapy, has not been elucidated sufficiently. The outcome in this group of patients was investigated. Serum HCV RNA levels...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.